Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 11/2006

01.11.2006 | Review

Ethics and research in critical care

verfasst von: Henry J. Silverman, Francois Lemaire

Erschienen in: Intensive Care Medicine | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

The past few years have witnessed several controversies regarding the ethics of conducting research involving critically ill patients, and such research is ethically challenging.

Discussion

Research ethics is a changing field, one that is influenced by empirical data, contemporary events, and new ideas regarding aspects of clinical trial design and protection of human subjects. We describe recent thoughts regarding several aspects of research ethics in the critical care context.

Conclusion

The ability of the research community to conduct research ethically and to maintain public trust would benefit from heightened awareness to the principles and requirements that govern such research.
Literatur
1.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979) The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. U.S. Government Printing Office, Washington
2.
Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283:2701–2711PubMedCrossRef
3.
Anonymous (2001) Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities L121:33–44
4.
London AJ, Kadane JB (2002) Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res 11:413–427PubMedCrossRef
5.
Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317:141–145PubMedCrossRef
6.
Dreyfuss D (2005) Is it better to consent to an RCT or to care? Intensive Care Med 31:345–355PubMedCrossRef
7.
Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892PubMedCrossRef
8.
Mann H, Djulbegovic B (2003) Choosing a control intervention for a randomised clinical trial. BMC Med Res Methodol 3:7PubMedCrossRef
9.
Silverman HJ, Miller FG (2004) Control group selection in critical care randomized controlled trials evaluating interventional strategies: An ethical assessment. Crit Care Med 32:852–857PubMedCrossRef
10.
Miller FG, Silverman HJ (2004) The ethical relevance of the standard of care in the design of clinical trials. Am J Respir Crit Care Med 169:562–564PubMedCrossRef
11.
Parshuram CS, Kavanagh BP (2004) Positive clinical trials. Understand the control group before implementing the result. Am J Respir Crit Care Med 170:223–226PubMedCrossRef
12.
Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Schiavi E, Jorge M, Pusajo J ea (1992) Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339:195–199PubMedCrossRef
13.
Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M, Canadian Critical Care Clinical Trials Group (2003) A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348:5–14PubMedCrossRef
14.
Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, Baud F, Boyer A, Brocahrd L, Teboul JL, for the French Pulmonary Artery Catheter Study Group (2003) Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome. A randomized controlled trial. JAMA 290:2713–2720PubMedCrossRef
15.
Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourme D, Brampton W, Williams D, Young DR, Rowan K, PAC-Man Study collaboration (2005) Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomized controlled trial. Lancet 366:472–477PubMedCrossRef
16.
SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256CrossRef
17.
Krishnan JA, Moore D, Roveson C, Rand CS, Fessler HE (2004) A prospective, controlled trial of a protocol-based strategy to discontinue mechanical ventilation. Am J Respir Crit Care Med 169:673–678PubMedCrossRef
18.
Randolph AG, Wjypij D, Venkataraman ST, Hanson JH, Gedeit rG, Meert KL, Luckett PM, Forbes P, Lilley M, Thompson J (2002) Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial. JAMA 288:2561–2568PubMedCrossRef
19.
Ely EW, Baker AM, Duagan DP, Burke HL, Smith AC, Kelly PT, Johnson MM, Browder RW, Bowton DL, Haponik EF (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335:1864–1869PubMedCrossRef
20.
Anonymous (2004) The ethical conduct of clinical research involving critically ill patients in the United States and Canada. Am J Respir Crit Care Med 170:1375–1384CrossRef
21.
NICE-SUGAR Study Investigators (2005) A multi-centre, open label, randomised controlled trial of two target ranges for glycaemic control in intensive care unit (ICU) patients. Availlable at: http://​controlled-trialscom/​isrctn/​trial/​ISRCTN0498275/​0/​04968275html, accessed 5 February 2006
22.
Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef
23.
Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Fihlo G, Kariralla RA, Deheinzeline D, Munoz C, Oliveria R (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354PubMedCrossRef
24.
Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
25.
Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510–1514PubMedCrossRef
26.
Bellomo R (2005) Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc 80:1546–1548PubMedCrossRef
27.
Parshuram C, Kavanagh B (1983) Meta-analysis of tidal volumes in ARDS. Am J Respir Crit Care Med 167:798
28.
Weijer C (2000) The ethical analysis of risk. J Law Med Ethics 28:344–361PubMed
29.
McRae AD, Weijer C (2002) Lessons from everyday lives: a moral justification for acute care research. Crit Care Med 30:1146–1151PubMedCrossRef
30.
National Bioethics Advisory Commission (2001) Ethical and policy issues in research involving human participants. U.S. Government Printing Office, Rockville
31.
Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192PubMed
32.
Lemaire F, Brun-Buisson C (2000) Are institutional review boards effective in safe-guarding patients in intensive care units? Curr Opin Anaesthesiol 13:195–200PubMedCrossRef
33.
Karlawish JHT (2003) Research involving cognitively impaired adults. N Engl J Med 348:1289–1392CrossRef
34.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1977) Research involving children: report and recommendations. U.S. Department of Health, Education and Welfare, Washington
35.
National Bioethics Advisory Commission (1998) Research involving persons with mental disorders that may affect decisionmaking capacity. U.S. Government Printing Office, Rockville
36.
World Medical Association (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. HIV Clin Trials 2001:92–95
37.
Morin K, Rakatansky H, Riddick FA et al. (2002) Managing conflicts of interest in the conduct of clinical trials. JAMA 287:78–84PubMedCrossRef
38.
University of California Office of the President Office of Research (2002) Guidance on surrogate consent for research. Available at: http://​www.​llnl.​gov/​HumanSubjects/​pdfs/​surrogate.​pdf; accessed 22 September 2003
39.
Saks ER (1999) Competency to decide on treatment and research. The MacArthur capacity instruments. In: National Bioethics Advisory Commission (ed) Research involving persons with mental disorders that may affect decisionmaking capacity,vol II. Commissioned papers. National Bioethics Advisory Commission, Rockville
40.
Silverman HJ, Luce JM, Schwartz J (2004) Protecting subjects with decisional impairment in research. The need for a multifaceted approach. Am J Respir Crit Care Med 169:10–14PubMedCrossRef
41.
Keyserlingk EW, Kogan GK, Gauthier S (1995) Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 38:319–361PubMed
42.
Lidz WW, Appelbaum PS (2002) The therapeutic misconception. Problems and solutions. Med Care 40:V55–V63PubMedCrossRef
43.
Dresser R (2002) The ubiquity and utility of the therapeutic misconception. Soc Philos Policy Foundation 19:271–294CrossRef
44.
Silverman HJ (1996) Ethical considerations of ensuring an informed and autonomous consent in research involving critically ill patients. Am J Respir Crit Care Med 154:582–586PubMed
45.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1997) Consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use. Int Dig Health Legis 48:231–234
46.
Silverman HJ, Hull SC, Sugarman J (2001) Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med 29:235–241PubMedCrossRef
47.
Advisory Committee on Human Radiation Experiments (1995) Final report. U.S. Government Printing Office, Washington
48.
Silverman HJ, Luce JM, Lanken PN, Morris AH, Harabin AL, Oldmixon CF, Thompson BT, Bernard GR, for the NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network (2005) Recommendations for informed consent forms for critical care clinical trials. Crit Care Med 33:867–882PubMedCrossRef
49.
Estey A, Wilkin G, Dossetor J (1994) Are research subjects able to retain the information they are given during the consent process. Health Law Rev 3:37–41
50.
Williams FF, French JK, White HD, for the HERO-2 consent substudy investigators (2003) Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. Lancet 361:918–922PubMedCrossRef
51.
Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK (1996) The impact of disease severity on the informed consent process in clinical research. Am J Med 100:261–268PubMedCrossRef
52.
Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17:20–24PubMed
53.
Miller FG, Rosenstein DL (2003) The therapeutic orientation to clinical trials. N Engl J Med 348:1383–1386PubMedCrossRef
54.
Lemaire F (2004) Patient care versus research: does clinical research provide individual benefit to patients enrolled in trials. Curr Opin Crit Care 10:565–569PubMedCrossRef
55.
Appelbaum PS (2002) Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception. Am J Bioethics 2:22–23CrossRef
56.
Clemens JD, Frederik FP, van Loon L, Rao M, Sack DA, Ahmed F, Chakraborty J, Khan MR, Yunus M, Harris JR, Svennerholm AM et al. (1992) Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines. Am J Epidemiol 135:865–874PubMed
57.
Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270PubMedCrossRef
58.
Hawkins JS, Emanuel EJ (2005) Clarifying confusions about coercion. Hastings Cent Rep 35:16–19PubMed
59.
Anonymous (2005) Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing of importation of such products. Official J Eur Union L91:13–19
60.
Sulmasy DP, Terry PB, Weisman CS, Miller DJ, Stallings RY, Vettese MA, Haller KB (1998) The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 128:621–629PubMed
61.
Coppolino M, Ackerson L (2001) Do surrogate decision makers provide accurate consent for intensive care research? Chest 119:603–612PubMedCrossRef
62.
Jones C, Skirrow P, Griffiths R, Humphris G, Ingleby S, Eddleston J, Waldmann C, Gager M (2004) Post-traumatic stress disorder-related symptoms in relatives of patients following intensive care. Intensive Care Med 30:456–460PubMedCrossRef
63.
Pochard F, Azoulay E, Chevret S, Lemaire F, Hubert P, Canoui P, Grassin M, Zittoun R, LeGall JR, Dhainaut JF, Schlemmer B, French FAMIRFA Group (2001) Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 29:1893–1897PubMedCrossRef
64.
United States Department of Health and Human Services (1996) Protection of human subjects: informed consent and waiver of informed consent requirements in certain emergency research. Final rules, 61. Fed Register 51500–51533
65.
Nichol G, Huszti E, Rokosh J, Dumbrell A, McGowan J, Becker L (2004) Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research? Resuscitation 62:3–23PubMedCrossRef
66.
Hiller KM, Haukoos JS, Heard K, Tashkin JS, Paradis NA (2005) Impact of the final rule on the rate of clinical cardiac arrest research in the United States. Acad Emerg Med 12:1091–1098PubMedCrossRef
67.
Lemaire F (2002) European Society of Intensive Care Medicine statement. Intensive Care Med 28:1218–1219PubMedCrossRef
68.
69.
Morse MA, Califf RM, Sugarman J (2001) Monitoring and ensuring safety during clinical research. JAMA 285:1201–1205PubMedCrossRef
Metadaten
Titel
Ethics and research in critical care
verfasst von
Henry J. Silverman
Francois Lemaire
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 11/2006
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-006-0305-4

Weitere Artikel der Ausgabe 11/2006

Intensive Care Medicine 11/2006 Zur Ausgabe

Pediatric Original

Epidemiology and Peculiarities of Pediatric Multiple Organ Dysfunction Syndrome in New Delhi, India

Correspondence

The catheter site influences in the micro-organism responsible of arterial catheter-related infection

Editorial

Expanding our horizons beyond the intensive care unit: does mechanism of lung injury influence the quality of life in ARDS survivors?

Systematic Review

A systematic review of the quality of genetic association studies in human sepsis

Original

Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation

Correspondence

A good death: another break in the wall

Neu im Fachgebiet AINS

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise